Sommaire

• • ·Title

    Page :i

    
• • ·Author Index

    Page :e1

    
• • ·CSANZ NZ Abstracts

    Page :e3

    
• • ·The impact of body mass index on mortality and cardiovascular events following acute coronary syndrome: Is there an obesity paradox?

    Page :e3

    J. Sathananthan, M. Lee, A. Kerr

    
• • ·Prasugrel inhibits platelet stimulation of pro-inflammatory T cells in humans

    Page :e3

    L. Johnston, A. La Flamme, P. Larsen, S. Harding

    
• • ·Stimulation of platelet toll-like receptors results in marked platelet activation that is partially inhibited by prasugrel but not aspirin

    Page :e4

    M. Bass, M. Chen-Xu, A. Sasse, A. La Flamme, P. Larsen, S. Harding

    
• • ·Novel ECG derived risk markers in implantable cardioverter defibrillator (ICD) patients

    Page :e4

    B. Shi, S. Harding, P. Larsen

    
• • ·Nurse led chest pain clinics: The south Auckland experience

    Page :e4

    C. Aldridge, A. McLachlan, S. Wong, A. Kerr, K. McLean

    
• • ·Supporting the achievement of Ministry of Health (MOH) cardiovascular disease (CVD) targets through an Inpatient CVD screening program in South Auckland

    Page :e5

    R. Swindells, C. Narbey, A. Alexander, A. Kerr, Y. Moh, A. McLachlan

    
• • ·Patient experience survey: Total ambulatory management and coronary angiography day stay procedures

    Page :e5

    S. Savage, T. Gudex, M. McAleer, P. Ruygrok, S. Madenholt-Titley, J. White

    
• • ·Same day discharge (SDD) for pecutaneous coronary intervention (PCI): A safe, effective, resource responsible strategy to improve the patient journey

    Page :e5

    J. Besley, S. Wilson

    
• • ·Slow for the amber or give it heaps? Traffic lights to prevent contrast induced nephropathy

    Page :e6

    R. Newcombe, G. Armstrong, A. Cave, C. Inocentes, S. El Jack, A. Khan

    
• • ·Factors contributing to failure to achieve a 10J safety margin in implantable cardioverter defibrillator testing

    Page :e6

    K. Singh, B. Shi, S. Bloomfield, G. Furniss, A. Jimenez, S. Harding, P. Larsen

    
• • ·Management and long-term outcome in heart failure (HF) associated with acute coronary syndrome (ACS) in a contemporary New Zealand cohort

    Page :e6

    A. Kueh, M. Lee, G. Devlin, A. Kerr

    
• • ·Paramedic initiated helivac to tertiary hospital for primary percutaneous coronary intervention: Initial experience and outcomes

    Page :e7

    P. Davis, P. Ruygrok, R. Howard, G. Howie

    
• • ·How many dialysis patients receive transplantation after achieving eligibility by undergoing coronary artery bypass grafting?

    Page :e7

    J. Sathananthan, H. Pilmore, J. De Zoysa, P. Ruygrok

    
• • ·Resumption of platelet function by verify-now assay after cessation of ticagelor in acute coronary syndrome patients awaiting surgical revascularisation

    Page :e8

    M. Lee, V. Pera, K. Sree Raman, G. Devlin, A. El-Gamel

     
• • ·Management of non ST-elevation acute coronary syndrome (NSTEACS) patients in New Zealand (NZ): A longitudinal analysis. Results from the NZACS national audits of 2002, 2007 and 2012

    Page :e8

    G. Devlin, A. Hamer, R. Throughton, G. Gamble, P. Matsis, M. Williams, J. Elliott, S. Mann, A. Richards, J. French, H. White, C. Ellis, for the NZ Regional Cardiac Society ACS Audit Group and the CSANZ ‘SNAPSHOT’ ACS Audit Group

    
• • ·A comparison of discharge medications and rehabilitation services available for acute coronary syndrome (ACS) patients in Australia and New Zealand: Results of the 2012 SNAPSHOT Bi-National audit

    Page :e9

    C. Ellis, T. Briffa, C. Hammet, J. French, J. Lefkovits, I. Ranasinghe, G. Devlin, J. Elliott, F. Turnbull, J. Redfern, B. Aliprandi-Costa, C. Astley, G. Gamble, D. Brieger, D. Chew, for the Bi-National Acute Coronary Syndromes (ACS) ‘SNAPSHOT’ Audit Group

    
• • ·Exposure to parental smoking in childhood is associated with increased risk of carotid atherosclerotic plaque in adults

    Page :e9

    H. West, C. Magnussen, M. Juonala, M. Kähönen, T. Laitinen, L. Taittonen, J. Viikari, O. Raitakari

    
• • ·Should indexation of left ventricular volume be sex and ethnic specific? A report from the EchoNoRMAL meta-analysis

    Page :e10

    K. Poppe, C. Triggs, I. Squire, I. Simova, A. Ng, L. Thomas, R. Hobbs, H. Dalen, R. Izzo, G. de Simone, G. Whalley, E. Rietzschel

    
• • ·Evaluation of cardiac axis changes related to obesity and aging by surface electrocardiogram and cardiac computed tomography

    Page :e10

    G. Sathananthan, W. Chik, S. Zahid, G. Aggarwal, D. Friedman, A. Thiagalingam

    
• • ·Diagnostic accuracy of different electrocardiographic and radiographic criteria for left atrial enlargement as assessed by cardiac magnetic resonance

    Page :e10

    S. Pumprueg, T. Boonyasirinant, S. Boorakham

    
• • ·Early outcome of transcatheter aortic-valve implantation in high risk patients: The Auckland experience from 2011 to 2014

    Page :e11

    S. Wu, J. Stewart, M. Webster, J. White

    
• • ·Pre-operative atrial fibrillation is independently associated with short and long-term mortality after aortic valve replacement

    Page :e11

    T. Wang, D. Choi, T. Ramanathan, P. Ruygrok

    
• • ·The prognostic value of T peak - T end interval on the surface ECG in patients undergoing reperfusion therapy for STEMI

    Page :e12

    B. John, S. Dey, J. Jacob, V. Raghavan

    
• • ·Cardiac sarcoidosis: The Christchurch experience

    Page :e12

    I. Melton, P.O. Adamson, J. Donnell, S. MacDonald, I. Crozier

    
• • ·The development and implementation of a real time, cardiac rehabilitation tracking system

    Page :e12

    A. McLachlan, K. McLean, S. Breen, A. Kerr

    
• • ·Polypills for high risk patients: Results of a New Zealand randomised controlled trial

    Page :e13

    V. Selak, C. Elley, S. Crengle, A. Wadham, N. Rafter, C. Bullen

    
• • ·The effects of ticagrelor on platelet reactivity and short term outcomes in acute coronary syndromes

    Page :e13

    A. Al-Sinan, P. Matsis, M. Simmonds, L. Johnston, P. Larsen, S. Harding

    
• • ·The fate of 302 patients receiving consecutive bio-prosthetic aortic valve replacements

    Page :e13

    M. Haydock, C. Wilkes, T. Ramanathan, D. Haydock

    
• • ·Comparison of four contemporary risk scores for predicting mortality and morbidity after aortic valve replacement

    Page :e14

    T. Wang, R. Stewart, D. Choi, G. Gamble, D. Haydock, P. Ruygrok

    
• • ·Acute coronary syndromes in patients with prior MI: Secondary prevention and outcomes

    Page :e14

    S. Fairley, S. Harding, M. Liang, A. Aitken, A. Ranchord, P. Larsen

    
• • ·Prevalence and predictors of right ventricular dysfunction in patients with left ventricular systolic dysfunction: Insights from cardiac magnetic resonance

    Page :e15

    T. Boonyasirinant, C. Charunwikan, R. Krittiyaphong

    
• • ·Radiation dose and positive predictive value of revascularisation with low dose myocardial perfusion scintigraphy compared with computed tomography coronary angiography

    Page :e15

    I. Subiakto, A. Ul Haq, A. Vlachadis Castles, W. Van Gaal

    
• • ·Temporary and permanent discontinuation of clopidogrel following acute coronary syndromes

    Page :e15

    D. Middleditch, B. Scott, M. Simmonds, A. Aitken, L. Johnston, P. Larsen, S. Harding

    
• • ·The effect of programming on therapy rates in implantable cardioverter defibrillator patients

    Page :e16

    S. Levings, M. Stiles, S. Heald, A. Jimenez, B. Shi, S. Harding, P. Larsen

    
• • ·The effect of cardiac surgery on the Q-T interval. Are patients at higher risk of torsades de pointes post cardiac surgery?

    Page :e16

    T. Pasley, M. Gillham

    
• • ·The left ventricular response todobutamine in patients after Apical Ballooning Syndrome compared to male and female controls

    Page :e17

    G. Sathananthan, J. Looi, A. Kerr

    
• • ·Clothing optional reducing patient anxiety during coronary angiography

    Page :e17

    H. Abernethy, J. Besley, S. Wilson

    
• • ·Early repeat transradial access for coronary angiography and percutaneous coronary intervention

    Page :e17

    E. Aiken, J. Money, B. Kneale

    
• • ·4F angiography is associated with less contrast usage, shorter procedure time and earlier discharge with preserved diagnostic utility - a comparison with 5F angiography

    Page :e18

    S. Prabhu, M. Freilich, N. Lonergan, M. Nguyen, N. Fishlock, C. Wimalagunasekera, N. Muir, D. Saleh, M. Arrowsmith, J. Layland

    
• • ·Cryoballoon ablation for atrial fibrillation

    Page :e18

    M. Arshad, M. Daly, I. Crozier, I. Melton

    
• • ·Second generation cryoballoons - are they any better?

    Page :e19

    M. Arshad, M. Daly, I. Crozier, I. Melton

    
• • ·Sever aortic stenosis-prevalence and management experience from the Bay of Plenty

    Page :e19

    M. Arshad, G. Porter

    
• • ·Acute coronary syndrome with non obstructive coronary angiography; Rates, treatment, and outcomes at Middlemore Hospital

    Page :e19

    P. Barr, A. Kerr

    
• • ·New Zealand's ‘approach’ to coronary angiography: A descriptive analysis of arterial access for invasive coronary angiography

    Page :e20

    P. Barr, C. Flynn, D. Smyth, A. Kerr

    
• • ·Cost effectiveness of transcatheter aortic valve implantation (TAVI) for patients with severe symptomatic aortic stenosis in New Zealand

    Page :e20

    S. Bhattacharyya, M. Roskruge, S. Haynes, T. Ramanathan, M. Webster, P. Ruygrok

    
• • ·Spatial QRS-T angle following acute coronary syndromes

    Page :e20

    S. Blomfield, B. Shi, S. Harding, P. Larsen

    
• • ·The cardiac sonographer workforce in NZ - Results from the 2013 SCANZ workforce survey

    Page :e21

    B. Buckley, M. Farnworth, S. White, G. Whalley

    
• • ·Post code lottery exists in echocardiography provision in New Zealand

    Page :e21

    B. Buckley, K. Poppe, M. Farnworth, G. Whalley

    
• • ·Is myocardial B1- and B2-adrenoceptor responsiveness altered in conscious Zucker Diabetic Fatty rats?

    Page :e21

    R. Cook, C. Bussey, P. Cragg, R. Lamberts

    
• • ·Electrophysiology assessment and radiofrequency ablation of arrhythmias in adult patients with congenital heart defects: The Christchurch experience

    Page :e22

    M. Daly, K. Frankish, J. Greenslade, S. Denekamp, J. Lainchbury, I. Melton, D. Hooks, I. Crozier

    
• • ·Implementation of a high sensitivity troponin assay reduces time spent in the emergency department by patients with a possible acute coronary syndrome

    Page :e22

    A. Early, R. Cooke, M. Nguyen, S. Mann

    
• • ·A decade of improvement in investigations received and treatments delivered to New Zealand (NZ) ST-elevation myocardial infarction (STEMI) patients: Results from the NZACS national audits of 2002, 2007 and 2012

    Page :e22

    J. Elliott, M. Williams, P. Matsis, G. Gamble, R. Troughton, A. Hamer, G. Devlin, S. Mann, A. Richards, J. French, H. White, C. Ellis, for the NZ Regional Cardiac Society ACS Audit Group and the CSANZ ‘SNAPSHOT’ ACS Audit Group

    
• • ·A comparison of invasive angiography, revascularisation and time delays delivered to Australian and New Zealand non-ST-elevation myocardial infarction/unstable angina pectoris (NSTEMI/UAP) patients: results of the 2012 SNAPSHOT Bi-National acute coronary Syndrome (ACS) audit

    Page :e23

    C. Ellis, C. Hammett, J. French, T. Briffa, J. Lefkovitz, I. Ranasinghe, G. Devlin, J. Elliott, F. Turbull, J. Redfern, B. Aliprandi-Costa, C. Astley, G. Gamble, D. Brieger, D. Chew, for the Bi-National Acute Coronary Syndromes (ACS) ‘SNAPSHOT’ Audit Group

     
• • ·Improved rates of secondary prevention medication following hospitalisation for an acute coronary syndrome (ACS) in New Zealand (NZ): Results from the NZ ACS national audits of 2002, 2007 and 2012

    Page :e23

    C. Ellis, G. Gamble, G. Devlin, J. Elliott, A. Hamer, P. Matsis, M. Williams, R. Troughton, S. Mann, J. French, A. Richards, H. White, for the NZ Regional Cardiac Society ACS Audit Group and the CSANZ ‘SNAPSHOT’ ACS Audit Group

    
• • ·Diabetes causes the activation of the pro-ageing miRNA-34a in the human heart

    Page :e24

    I. Fomison-Nurse, P. Saxena, S. Coffey, A. Menon, R. Bunton, I. Galvin, A. Bahn, M. Williams, V. Cameron, R. Katare

    
• • ·Stent length and GP2B/3A Inhibitor use but not eGFR predict peri-procedural myocardial infarction in elective percutaneous coronary intervention

    Page :e24

    C. Goh, A. Al-Fiadh, D. Clark, O. Farouque

    
• • ·Ticagrelor in the management of acute coronary syndromes

    Page :e25

    S. Green, T. Cherian, C. Heald, M. Lee, G. Devlin

    
• • ·Introduction and evaluation of total ambulatory management of patients undergoing coronary angiography and intervention

    Page :e25

    T. Gudex, S. Madenholt-Titley, M. McAleer, S. Savage, J. White, P. Ruygrok

    
• • ·Platelet count and platelet function testing in acute coronary syndromes

    Page :e26

    K. Hally, L. Johnston, A. Holley, P. Larsen, S. Harding

    
• • ·Low prevalence of left atrial thrombus detected by transoesphageal echocardiogram in patients with arrhythmia prior to DC cardioversion

    Page :e26

    D. Hare, A. Pope, S. Kueh, J. Looi, N. van Pelt, R. Gabriel

    
• • ·Characteristics, outcomes, and complications during the first year of coronary rotational atherectomy at Middlemore Hospital

    Page :e26

    W. Harrison, R. McIntosh, S. Graham, C. Flynn, A. Escondo, P. Kay

    
• • ·Short to medium term outcome of Bioresorbable Scaffolds for treatment of coronary stenosis: The Christchurch experience

    Page :e27

    T. Hii, D. McClean, A. Puri, J. Blake, J. Elliott, D. Smyth

    
• • ·Variability and prognostic significance of antioxidant enzymes in acute coronary syndromes (ACS)

    Page :e27

    A. Holley, J. Miller, S. Harding, P. Larsen

    
• • ·Effects of pre-hospital ECG transmission for ST-elevation myocardial infarction in Counties Manukau

    Page :e27

    M. Jain, A. Loh, M. Lee, D. Hailstone, A. Kerr

    
• • ·Trastuzumab induced cardiotoxicity in Auckland

    Page :e28

    K. Johnson, J. Signy, J. Pemberton, J. Cadogan

    
• • ·Management of valvular heart disease: Role of echocardiography and assessment of pulmonary hypertension reversibility

    Page :e28

    K. Khokhar, G. Devlin, A. El-Gamel, R. Fisher, P. Jogia

    
• • ·Percutaneous coronary intervention (PCI) outcomes at Tauranga Hospital: A new non-surgical centre's early experience

    Page :e29

    B. Kneale, J. Money

    
• • ·Cryoablation for AF in the Waikato; Early results

    Page :e29

    E. Kooijman, I. Grey, R. Allen, S. Heald, D. Boddington, M. Stiles

    
• • ·Clinical characteristics and outcomes of patients with P-associated cardiomyopathy (PAC) in Auckland, New Zealand

    Page :e30

    A. Kueh, J. Bradley, T. Sutton, R. Gabriel, M. Lund, J. Looi

    
• • ·Long-term clinical outcome of patient with type I vs type II non-STEMI

    Page :e30

    A. Kueh, M. Lee, A. Kerr

    
• • ·Warfarin vs Dabigatran for elective direct current cardioversion (DCCV)

    Page :e30

    A. Kueh, D. Judson, K. Reed, R. Gabriel, J. Looi, D. Heaven, N. van Pelt

    
• • ·Does timing of platelet function testing (PFT) contribute to variability in residual on-treatment platelet reactivity in patients with acute coronary syndrome (ACS)?

    Page :e31

    C. Legge, A. Al-Sinan, A. Holley, L. Johnston, P. Larsen, S. Harding

    
• • ·This abstract has been withdrawn

    Page :e31

    
• • ·This abstract has been withdrawn

    Page :e31

    
• • ·Prevalence and predictors of subclinical coronary artery disease in patients with confirmed heterozygous familial hypercholesterolaemia

    Page :e31

    J. Lumby, A. Moffat, T. Bates, G. Watts, A. Abraham

    
• • ·Reduced sedation in patients undergoing coronary angiography of total ambulatory management

    Page :e32

    S. MadenHolt-Titley, T. Gudex, M. McAleer, S. Savage, J. White, P. Ruygrok

    
• • ·Audit of the burden of rheumatic heart disease in the Wellington region

    Page :e32

    M. Margetts, A. Aitken, N. Wilson

    
• • ·Transcatheter aortic valve implantation in patients with percutaneous coronary intervention to the left main coronary artery

    Page :e32

    A. Maurice, S. Chan, D. Murdoch, A. Clarke, D. Walters

    
• • ·The use of gastrointestinal cocktail for excluding myocardial ischaemia in the emergency setting: A systematic review

    Page :e33

    S. Chan, A. Maurice, S. Davies, D. Walters

    
• • ·Total ambulatory care (TAC) for day-stay coronary angiography patients (Amsterdam protocol): A positive response with suggested enhancements

    Page :e33

    M. McAleer, S. Madenholt-Titley, S. Savage, T. Gudex, J. White, P. Ruygrok

    
• • ·Interventional nursing perspective on seting up of a coronary rotational atherectomy service: First-year experiences and lessons learnt

    Page :e34

    R. McIntosh, S. Graham, W. Harrison, C. Flynn, A. Escondo, P. Kay

    
• • ·Are guidelines adhered to at first assessment of atrial fibrillation

    Page :e34

    I. Melton, L. Lim

    
• • ·Regional transfer; How much do patients know?

    Page :e34

    C. Mercier, G. Aldrich

    
• • ·Pathological autophagy augments cell death in the diabetic heart

    Page :e35

    E. Munasinghe, I. Fomison-Nurse, G. Hughes, P. Saxena, R. Bunton, I. Galvin, R. Katare

    
• • ·Outcomes of structural interventions in a hospital without onsite cardiothoracic surgery

    Page :e35

    R. Parameswaran, S. Koneru, R. Miller, G. Koshy, B. Herman

    
• • ·Fulminant myocarditis

    Page :e35

    K. Park, J. Beca, A. McKee, A. McGeorge, C. Wasywich, P. Ruygrok, N. Kingston, A. Coverdale

    
• • ·“Murmur clinic” - A novel use of cardiology resources to address an unmet need

    Page :e36

    T. Pasley, G. Porter

    
• • ·An audit of EP procedures and complications

    Page :e36

    T. Pasley, D. Boddington, S. Buttle

    
• • ·“Normal” coronary arteries in the setting of acute coronary syndrome: Frequency and outcomes

    Page :e36

    S. Plunkett, A. Ranchord, P. Matsis, A. Holley, P. Larsen, S. Harding

    
• • ·The development of a structured and cohesive service for people admitted to hospital with a diagnosis of heart failure. The 20,000 days campaign

    Page :e37

    J. Poole, A. McLachlan, L. Morley, S. Mooney, T. Sutton, A. Howitt, K. McLean, M. Lund

    
• • ·Can significant coronary artery disease be ruled out by CT coronary angiography in patients weighing greater than 100 kg?

    Page :e37

    A. Pope, A. Fyfe, R. Gabriel, J. Looi, D. Burt, S. Barnard, S. Tang, P. Weeks, F. Wu, N. van Pelt

    
• • ·CT coronary angiography can safely exclude significant coronary artery disease in patients undergoing valve and aorta surgery

    Page :e38

    A. Pope, A. Fyfe, R. Gabriel, J. Looi, S. Barnard, S. Tang, P. Weeks, F. Wu, N. van Pelt

    
• • ·Five year outcomes following pericardiocentesis in Middlemore Hospital patients

    Page :e38

    A. Pope, A. Jebb, T. Sutton

    
• • ·Circulating cardiovascular microRNAs as diagnostic biomarkers for early diagnosis of diabetic heart disease

    Page :e38

    S. Rawal, J. Paulin, E. Munasinghe, P. Manning, R. Katare

    
• • ·Novel approach to improving cardiac rehabilitation for all: The whanau ora way

    Page :e39

    L. Sami, S. Christophers, A. Kerr, A. Mclachan

    
• • ·Percutaneous coronary intervention rates and outcomes of coronary angiography in patients with prior CABG - an ANZACS-QI single centre study

    Page :e39

    G. Sathananthan, C. Flynn, D. Scott, P. Kay, W. Harrison, A. Kerr

    
• • ·This abstract has been withdrawn

    Page :e39

    
• • ·TAVI in New Zealand; A cost effective treatment for patients with aortic stenosis at high surgical risk?

    Page :e39

    D. Smyth, J. Blake, R. Troughton, M. Hart, G. Roper, D. Williams, H. Singh

    
• • ·Balloon aortic valvuloplasty (BAV) for the management of severe aortic stenosis in the era of transcatheter aortic valve implantation (TAVI)

    Page :e40

    K. Sree Raman, R. Nair, G. Devlin, S. Pasupati

    
• • ·How well are we doing in secondary prevention after myocardial infarction - The STABILITY study experience

    Page :e40

    R. Stewart, J. Benetar, A. Hamer, D. Scott, G. Devom, H. Hart, J. Elliott, J. Tisch, L. Davidson, M. Hills, N. Harrison, R. Rankin, T. O’Meeghan, V. Chen, H. White

    
• • ·Bleeding risk and incidence in real world percutaneous coronary intervention patients with ticagrelor

    Page :e41

    I. Subiakto, A. Ul Haq, W. Van Gaal

    
• • ·APACHE III score predicts mortality in out of hospital cardiac arrest (OOHCA) patients with ST elevation myocardial infarction (STEMI)

    Page :e41

    C. Tie, T. Kuang, J. Loubser, C. Frampton, D. Knight, D. Smyth

    
• • ·APACHE III score predicts mortality in out of hospital cardiac arrest (OOHCA) patients with non-ST elevation myocardial infarction (NSTEMI)

    Page :e42

    C. Tie, T. Kuang, J. Loubser, C. Frampton, D. Knight, D. Smyth

    
• • ·Prevalence of obstructive coronary artery disease among patients undergoing coronary angiography at an Australian Tertiary Hospital

    Page :e42

    D. Tsang, M. Yudi, S. Joshi

    
• • ·The Australian experience of government subsidisation of novel oral anticoagulants (NOACs)

    Page :e42

    A. Vlachadis Castles, W. van Gaal

     
• • ·AV junction ablation audit - Auckland City Hospital

    Page :e43

    J. Voss, L. Maher, C. Jones, N. Lever

    
• • ·Cardioplegia in contemporary coronary artery bypass grafting: Effects on high-sensitivity troponins and outcomes

    Page :e43

    T. Wang, A. Li, T. Wilcox, H. White, T. Ramanathan

    
• • ·Comparison of society of thoracic surgeon's risk models with EuroSCORE and EuroSCORE II at adverse outcome prediction after coronary artery bypass grafting

    Page :e44

    T. Wang, A. Li, T. Ramanathan, G. Gamble, R. Stewart, H. White

    
• • ·Diagnosis of myocardial infarction after aortic valve replacement with high-sensitivity troponins

    Page :e44

    T. Wang, R. Stewart, T. Ramanathan, D. Choi, G. Gamble, P. Ruygrok, H. White

    
• • ·Disparities of outcomes between Pacific Island and European patients undergoing coronary artery bypass grafting

    Page :e44

    T. Wang, R. Stewart, T. Ramanathan, G. Gamble, H. White

    
• • ·Elevation of aspartate aminotransferase predicts mortality after coronary artery bypass grafting

    Page :e45

    T. Wang, R. Stewart, T. Ramanathan, G. Gamble, H. White

    
• • ·Features and outcomes of eosinophilic myocarditis: A single-centre case series

    Page :e45

    T. Wang, T. Watson, B. Lowe, J. Pemberton, N. Kingston, C. Ellis, P. Ruygrok

    
• • ·Influence of cardioplegia techniques on outcomes after aortic valve replacement

    Page :e46

    T. Wang, D. Choi, T. Wilcox, H. White, T. Ramanathan

    
• • ·Relationships between anticoagulation regimen, risk score and adverse outcomes in dialysis patients with atrial fibrillation

    Page :e46

    T. Wang, J. Sathananthan, C. Hood, G. Gamble, M. Marshall, A. Kerr

    
• • ·Seven tear study of surgery for infective endocarditis: The contemporary Auckland City Hospital experience

    Page :e46

    T. Wang, T. Oh, J. Voss, N. Kang, J. Pemberton

    
• • ·Utility of pre-catheterisation high-sensitivity troponin T in patients without obstructive coronary artery disease

    Page :e47

    T. Wang, T. Oh, C. Samaranayake, T. Watson, J. Stewart, M. Webster, P. Ruygrok

    
• • ·Value of normal or mild coronary artery disease on angiography during workup of suspected angina pectoris

    Page :e47

    T. Wang, T. Oh, C. Samaranayake, T. Watson, J. Stewart, M. Webster, C. Ellis, P. Ruygrok

    
• • ·3D echo mitral valve reconstruction - validity of a novel software application

    Page :e48

    M. Wolbinski, A. Morgan, P. Larsen, A. Sasse

    
• • ·CT coronary angiography reporting in New Zealand. A survey of practitioners

    Page :e48

    C. Young